Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

P1. Pediatric Bacterial studies (natural history and therapuetic)

Poster Session: Pediatric Bacterial Studies

(P-444) Population Pharmacokinetics (PPK) Analysis of Sulbactam-Durlobactam (SUD) to Support Dose Selection for Evaluation in a Clinical Trial in Pediatric Patients with Acinetobacter Baumannii-Calcoaceticus Complex (ABC) Infections

Monday, October 20, 2025
12:15 PM - 1:30 PM US ET
Location: Poster Hall B4-B5

    Co-Author(s)

  • KL

    Kajal B. Larson, PhD

    Sr. Director, Clinical Pharmacology and Clinical Development
    Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc.
    Waltham, MA, United States

    • Co-Author(s)

  • JO

    John O'Donnell, BS

    AUROBAC Therapeutics
    Boston, Massachusetts, United States

    • Presenting Author(s)

  • Angela Tanudra, MS (she/her/hers)

    Associate Director Clinical Sciences
    Innoviva Specialty Therapeutics, Inc.
    Waltham, MA, United States

    • Co-Author(s)

  • AC

    Anthony P. Cammarata, M.S.

    Institute for Clinical Pharmacodynamics
    Schenectady, New York, United States

  • CR

    Christopher M. Rubino, PharmD

    Executive Vice President
    Institute for Clinical Pharmacodynamics
    Schenectady, New York, United States